| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.09 |